

PT-141, also catalogued as bremelanotide, is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone and a melanocortin receptor agonist.
PT-141, also catalogued as bremelanotide, is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone and a melanocortin receptor agonist.
It is a metabolite of Melanotan II, differing at the C-terminus: PT-141 carries a free carboxylic acid where Melanotan II is amidated. That single difference substantially shifts the receptor-subtype selectivity profile, which is why the two are studied as distinct compounds rather than as variants.
The lactam bridge that closes the ring is stable under normal handling but the tryptophan residue makes the sequence light-sensitive.
| Compound name | PT-141 |
| Classification | Endocrine research compound |
| CAS number | 189691-06-3 |
| Molecular formula | C50H68N14O10 |
| Molecular weight | 1025.18 g/mol |
| Sequence | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Purity (this lot) | 99.3% by RP-HPLC |
| Endotoxin | <0.5 EU/mg by LAL |
| Appearance | White to off-white lyophilized powder |
| Vial size | 10 mg |
| Solubility | Soluble in sterile water |
| Storage | Lyophilized: -20 C, desiccated, protected from light. Reconstituted: 2-8 C, use within 30 days. |
| Released lot | PS-3230947 |
Vials arrive lyophilized and sealed under nitrogen. Bring the vial fully to room temperature before breaking the seal — opening a cold vial condenses atmospheric moisture onto the cake.
Direct diluent gently against the inside wall of the vial rather than onto the cake, and allow the material to dissolve without agitation. Vortexing shears longer sequences and introduces air.
Lyophilized: -20 C, desiccated, protected from light. Reconstituted: 2-8 C, use within 30 days.
A full walkthrough is in the reconstitution guide, and the calculator will work out concentration and draw volume for this vial size.
Standard laboratory practice applies: appropriate personal protective equipment, no consumption, no administration to humans or animals, and disposal in accordance with institutional protocol and local regulation.
Both certificates below were generated against this specific lot and published before it was released to stock. Enter the lot number in the certificate lookup to retrieve them at any time. New to reading these? See how to read a certificate of analysis.
PT-141 has a free C-terminal acid; Melanotan II is amidated. That difference changes melanocortin receptor subtype selectivity.
Yes - bremelanotide is the non-proprietary name for PT-141.
Yes, because of the tryptophan residue. Keep vials in secondary packaging.
PT-141 is supplied for in-vitro laboratory research only. It is not a drug, dietary supplement, food or cosmetic, is not approved by the FDA for any use in humans or animals, and no dosing guidance is published for it. Nothing on this page is a therapeutic, structure–function or health claim. Purchasers must be 21 or over and are responsible for compliance with all applicable law. Full terms of supply.